IRS2 expression is higher in aggressive, metastatic human breast carcinoma cell lines [16], and mammary tumor cells that are deficient for IRS2 expression are significantly more sensitive to apoptotic stimuli, such as serum deprivation [16, 20, 21]. Here, IRS2 is linked to breast carcinoma.